Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AM-4668 is a type 2 diabetes GPR40 agonist. For GPR40, in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), the EC50s are 3.6 nM and 36 nM, respectively.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | AM-4668 is a type 2 diabetes GPR40 agonist. For GPR40, in A9 cells (GPR40 IP3 assay) and CHO cells (GPR40 aequorin assay), the EC50s are 3.6 nM and 36 nM, respectively. |
ターゲット&IC50 | FFA1/GPR40:(EC50)3.6 nM, FFA1/GPR40 (in CHO cells):36 nM(EC50) |
分子量 | 488.48 |
分子式 | C24H19F3N2O4S |
CAS No. | 1011531-27-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AM-4668 1011531-27-3 Endocrinology/Hormones GPCR/G Protein GPR AM 4668 AM4668 Inhibitor inhibitor inhibit